iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Trading Up 2.6% – Should You Buy?

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRNGet Free Report)’s share price shot up 2.6% on Friday . The company traded as high as $29.61 and last traded at $29.61. Approximately 600 shares changed hands during mid-day trading, a decline of 22% from the average session volume of 767 shares. The stock had previously closed at $28.85.

iShares Neuroscience and Healthcare ETF Trading Up 2.6%

The firm’s 50 day simple moving average is $27.76 and its 200-day simple moving average is $24.68. The stock has a market capitalization of $4.44 million, a price-to-earnings ratio of 15.61 and a beta of 0.93.

iShares Neuroscience and Healthcare ETF Company Profile

(Get Free Report)

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.

Featured Articles

Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.